Patients with psychotic disorders in solid-organ transplant

被引:14
|
作者
Zimbrean, Paula [1 ]
Emre, Sukru [1 ]
机构
[1] Yale Univ, New Haven, CT USA
关键词
INTENSIVE-CARE-UNIT; RENAL-TRANSPLANTATION; LIVER-TRANSPLANTATION; HEART-TRANSPLANT; SCHIZOPHRENIA; OUTCOMES; MORTALITY; DELIRIUM;
D O I
10.7182/pit2015296
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background-Psychotic disorders are considered a relative or absolute contraindication to organ transplant, but information about their impact on transplant is limited. Objective-To describe the clinical course of psychotic patients while they were on the waiting list and the outcomes of patients with psychotic disorders undergoing evaluation for organ transplant. Methods-Thirty-eight transplant candidates with a diagnosis of psychotic disorder were analyzed in this descriptive study. The following variables were collected before transplant: demographics, type of transplant, cause of organ failure, medical comorbid conditions, and psychiatric variables (diagnosis, hospitalizations, treatment, substance abuse, family history, suicide attempts). For transplant recipients, the following posttransplant variables were recorded: rejection, toxic effects of medication, nonadherence, psychotic episodes (number, time interval after transplant), and number of hospitalizations. Results-Of the 38 transplant candidates, 34 had a history of psychotic disorder before transplant. Nineteen (56%) of the 34 were listed for transplant, and 10 (29%) underwent transplant. Median follow-up time was 1.9 (IQR, 0.16-17.9) years. Among organ recipients with a history of psychotic disorders, psychiatric hospitalizations were 0.42 per patient per year (PPY), psychotic episodes 0.68 PPY, rejection 0.21 PPY, and toxic effects of immunosuppressants 0.05 PPY. None of the recipients lost their graft. Conclusions-Patients with a history of psychotic disorder can do well after organ transplant. Further studies are needed with factor analyses including severity of psychosis, medication adherence, and associated comorbid conditions. (C) 2015 NATCO, The Organization for Transplant Professionals
引用
收藏
页码:289 / 296
页数:8
相关论文
共 50 条
  • [1] SEPSIS IN SOLID-ORGAN TRANSPLANT PATIENTS
    Bafi, Antonio Tonete
    Vieira Tomotani, Daniere Yurie
    Rezende de Freitas, Flavio Geraldo
    [J]. SHOCK, 2017, 47 (01): : 12 - 16
  • [2] Mental Health Disorders and Solid-Organ Transplant Recipients
    Corbett, Chris
    Armstrong, Matthew J.
    Parker, Richard
    Webb, Kerry
    Neuberger, James M.
    [J]. TRANSPLANTATION, 2013, 96 (07) : 593 - 600
  • [3] Tolerance in Solid-Organ Transplant
    Fine, Richard N.
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 : 1 - 5
  • [4] Pulmonary complications in patients receiving a solid-organ transplant
    De Gasperi, Andrea
    Feltracco, Paolo
    Ceravola, Elias
    Mazza, Ernestina
    [J]. CURRENT OPINION IN CRITICAL CARE, 2014, 20 (04) : 411 - 419
  • [5] Safety and Efficacy of Tirzepatide in Patients with Solid-Organ Transplant
    Dowlatshahi, Samaneh
    Patham, Bhargavi
    Kansara, Abhishek
    Rogers, Alex W.
    Sadhu, Archana R.
    [J]. DIABETES, 2024, 73
  • [6] Bone Marrow Involvement by Lymphoproliferative Disorders After Solid-Organ Transplant
    Ozkan, Eylem Akar
    Ozdemir, B. Handan
    Akcay, Eda Yilmaz
    Terzi, Aysen
    Karakus, Sema
    Haberal, Mehmet
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2015, 13 : 183 - 187
  • [7] Post-transplant lymphoproliferative disorders following solid-organ transplantation
    Blaes, Anne H.
    Morrison, Vicki A.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (01) : 35 - 44
  • [8] Polyomaviruses in solid-organ transplant recipients
    Vilchez, RA
    Butel, JS
    Kusne, S
    [J]. TRANSPLANTATION, 2002, 74 (04) : 579 - 580
  • [9] Cell Therapy in Solid-Organ Transplant
    Argani, Hassan
    [J]. EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2016, 14 : 6 - 13
  • [10] Solid-Organ Transplant Pharmacotherapy 101
    Lukens, Benjamin
    Miko, Leadra
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2014, 10 (08): : 621 - 622